Sumitomo Mitsui Trust Group Inc. Lowers Position in Henry Schein, Inc. (NASDAQ:HSIC)

Sumitomo Mitsui Trust Group Inc. trimmed its holdings in shares of Henry Schein, Inc. (NASDAQ:HSIC - Free Report) by 98.2% in the 1st quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 5,025 shares of the company's stock after selling 269,891 shares during the quarter. Sumitomo Mitsui Trust Group Inc.'s holdings in Henry Schein were worth $344,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other institutional investors have also added to or reduced their stakes in the business. Smartleaf Asset Management LLC grew its holdings in shares of Henry Schein by 23.2% during the fourth quarter. Smartleaf Asset Management LLC now owns 759 shares of the company's stock worth $52,000 after purchasing an additional 143 shares in the last quarter. Guggenheim Capital LLC grew its stake in Henry Schein by 2.5% in the 4th quarter. Guggenheim Capital LLC now owns 6,428 shares of the company's stock worth $445,000 after buying an additional 159 shares in the last quarter. UMB Bank n.a. grew its stake in Henry Schein by 23.2% in the 1st quarter. UMB Bank n.a. now owns 1,066 shares of the company's stock worth $73,000 after buying an additional 201 shares in the last quarter. Humankind Investments LLC increased its holdings in shares of Henry Schein by 7.4% in the 4th quarter. Humankind Investments LLC now owns 3,057 shares of the company's stock worth $212,000 after buying an additional 211 shares during the last quarter. Finally, J. Safra Sarasin Holding AG raised its position in shares of Henry Schein by 1.1% during the 4th quarter. J. Safra Sarasin Holding AG now owns 22,098 shares of the company's stock valued at $1,529,000 after buying an additional 231 shares in the last quarter. 96.62% of the stock is currently owned by institutional investors.

Analyst Ratings Changes

HSIC has been the topic of a number of research reports. Wall Street Zen downgraded Henry Schein from a "buy" rating to a "hold" rating in a research report on Thursday, April 17th. Wells Fargo & Company decreased their price objective on Henry Schein from $80.00 to $75.00 and set an "equal weight" rating on the stock in a report on Tuesday, May 6th. Piper Sandler dropped their target price on Henry Schein from $83.00 to $77.00 and set an "overweight" rating for the company in a research report on Wednesday, April 30th. Finally, Barrington Research reduced their price target on shares of Henry Schein from $90.00 to $86.00 and set an "outperform" rating on the stock in a research report on Tuesday, May 6th. Six analysts have rated the stock with a hold rating, five have given a buy rating and one has issued a strong buy rating to the company. According to data from MarketBeat.com, the stock presently has a consensus rating of "Moderate Buy" and an average target price of $79.30.

Henry Schein Trading Up 0.2%

NASDAQ:HSIC opened at $74.67 on Friday. The firm has a market capitalization of $9.09 billion, a P/E ratio of 23.33, a P/E/G ratio of 2.41 and a beta of 0.87. The company has a quick ratio of 0.75, a current ratio of 1.38 and a debt-to-equity ratio of 0.50. The company has a fifty day moving average of $70.70 and a 200 day moving average of $71.19. Henry Schein, Inc. has a 52 week low of $60.56 and a 52 week high of $82.49.

Henry Schein (NASDAQ:HSIC - Get Free Report) last posted its earnings results on Monday, May 5th. The company reported $1.15 earnings per share for the quarter, topping analysts' consensus estimates of $1.11 by $0.04. The company had revenue of $3.17 billion during the quarter, compared to analyst estimates of $3.24 billion. Henry Schein had a net margin of 3.21% and a return on equity of 14.87%. Henry Schein's revenue for the quarter was down .1% on a year-over-year basis. During the same period in the prior year, the business posted $1.10 earnings per share. On average, research analysts predict that Henry Schein, Inc. will post 4.74 earnings per share for the current year.

Henry Schein Company Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.